K.‐M. Chang

发表

Strain-Speciﬁc T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection

K. Sugimoto, F. Nunes, H. Alter, 2005 .

Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV‐co‐infected patients initiating tenofovir‐based therapy

A. Localio, J. Kostman, K. Mounzer, 2014, Journal of viral hepatitis.

Black patients with chronic hepatitis C have a lower sustained viral response rate than non‐Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin *

E. Bini, M. Pedrosa, C. Hagedorn, 2006, Journal of viral hepatitis.

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

F. Chisari, M. Houghton, B. Rehermann, 1996, The Journal of clinical investigation.

Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.

A Sette, J Sidney, J. Sidney, 1999, Journal of immunology.

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

C. Rice, F. Chisari, M. Houghton, 1996, Journal of virology.

A global scientific strategy to cure hepatitis B.

Joan M. Block, J. Fellay, F. Chisari, 2019, The lancet. Gastroenterology & hepatology.

Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.

G. Freeman, E. Wherry, E. Gostick, 2008, Gastroenterology.

Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment

J. Hoofnagle, A. Lok, M. Ghany, 2017, Journal of viral hepatitis.